Keyphrases
Intensive Care Unit
100%
Indonesia
96%
Carbapenem-susceptible
63%
Jakarta
61%
Pseudomonas Aeruginosa (P. aeruginosa)
45%
Referral Hospital
43%
COVID-19
36%
Quantitative PCR
33%
Indonesian
29%
Carbapenemase Genes
24%
Klebsiella Pneumoniae (K. pneumoniae)
22%
Acinetobacter Baumannii (A. baumannii)
21%
High Risk
17%
International Clone
16%
Infection Control Interventions
16%
Antimicrobial Resistance
16%
Baumannii
14%
Cycle Threshold
13%
Low-middle Income Countries
13%
Epidemiology
12%
Carbapenemase
10%
Hand Hygiene
10%
Core Genome multilocus Sequence Typing (cgMLST)
10%
Gram-negative Bacteria
10%
Clinical Microbiology Laboratory
10%
Enterobacteriaceae
10%
Carbapenem Resistance
9%
Developing Countries
9%
Coronavirus
9%
Clinical Impact
9%
ST235
8%
BlaNDM-1
8%
Blimp-1
8%
Hand Hygiene Compliance
8%
Interrupted Time Series
8%
Multimodal Intervention
8%
Blood Isolates
8%
Acinetobacter Calcoaceticus
8%
Single nucleotide Polymorphism Analysis
8%
Epidemiological Typing
8%
Infection Resistance
8%
Acute Respiratory Symptoms
8%
Improvement Program
8%
Progress Management
8%
Bacterial Pathogens
8%
Whole Genome
8%
Universitas Indonesia
8%
Cervical Tuberculosis
8%
PCR Kit
8%
β-lactamase
8%
Medicine and Dentistry
Carbapenem
69%
Intensive Care Unit
66%
Pseudomonas aeruginosa
38%
Patient Referral
34%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Antibiotic Resistance
25%
Pathogen
19%
Carbapenemase
18%
Infection Control
16%
COVID-19
16%
Systematic Review
16%
Cohort Effect
15%
Klebsiella pneumoniae
14%
Infection
14%
Diagnosis
12%
Acinetobacter Baumannii
12%
Polymerase Chain Reaction
11%
Escherichia coli
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Gram-Negative Bacteria
9%
Cross Sectional Study
9%
Prevalence
8%
Beta-Lactamase
8%
Acinetobacter Calcoaceticus-Baumannii Complex
8%
Infection Resistance
8%
Coronavirinae
8%
COVID-19 Diagnostics
8%
Cervical Cancer
8%
Time Series Analysis
8%
Clinician
8%
Medical Procedures
8%
Nasopharyngeal Swab
8%
Tertiary Care
8%
Symptom
8%
Enterobacteriaceae
8%
Diarrhea
8%
Multidrug-Resistant Gram-Negative Bacteria
8%
Extended Spectrum Beta Lactamase
6%
